AAAAAA

   
Results: << | 201-225 | 226-250 | 251-275 | 276-300 | >>

Table of contents of journal: The *Prostate

Results: 276-300/1162

Authors: Cohen, RJ McNeal, JE Baillie, T
Citation: Rj. Cohen et al., Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: Significance for cancer progression, PROSTATE, 43(1), 2000, pp. 11-19

Authors: Janssen, M Albrecht, M Moschler, O Renneberg, H Fritz, B Aumuller, G Konrad, L
Citation: M. Janssen et al., Cell lineage characteristics of human prostatic stromal cells cultured in vitro, PROSTATE, 43(1), 2000, pp. 20-30

Authors: El Etreby, MF Liang, YY Lewis, RW
Citation: Mf. El Etreby et al., Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture, PROSTATE, 43(1), 2000, pp. 31-42

Authors: Ikonen, S Karkkainen, P Kivisaari, L Salo, JO Taari, K Vehmas, T Tervahartiala, P Rannikko, S
Citation: S. Ikonen et al., Magnetic resonance imaging of prostatic cancer: Does detection vary between high and low gleason score tumors?, PROSTATE, 43(1), 2000, pp. 43-48

Authors: Van Coppenolle, F Le Bourhis, X Carpentier, F Delaby, G Cousse, H Raynaud, JP Dupouy, JP Prevarskaya, N
Citation: F. Van Coppenolle et al., Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon (R)) on rat prostate hyperplasia induced by hyperprolactinemia: Comparison with finasteride, PROSTATE, 43(1), 2000, pp. 49-58

Authors: Murphy, GP Tjoa, BA Simmons, SJ Rogers, MK Kenny, GM Jarisch, J
Citation: Gp. Murphy et al., Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients, PROSTATE, 43(1), 2000, pp. 59-62

Authors: Buhler, KR Santucci, RA Royal, RA Whitney, SC Vessella, RL Lange, PH Ellis, WJ
Citation: Kr. Buhler et al., Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model, PROSTATE, 43(1), 2000, pp. 63-70

Authors: Pollard, M Wolter, WR Sun, LH
Citation: M. Pollard et al., Prostate-seminal vesicle cancers induced in Noble rats, PROSTATE, 43(1), 2000, pp. 71-74

Authors: Dennis, LK Resnick, MI
Citation: Lk. Dennis et Mi. Resnick, Analysis of recent trends in prostate cancer incidence and mortality, PROSTATE, 42(4), 2000, pp. 247-252

Authors: Johansson, S Landstrom, M Bjermer, L Henriksson, R
Citation: S. Johansson et al., Effects of tobacco smoke on tumor growth and radiation response of DunningR3327 prostate adenocarcinoma in rats, PROSTATE, 42(4), 2000, pp. 253-259

Authors: Marcelli, M Marani, M Li, XY Sturgis, L Haidacher, SJ Trial, JA Mannucci, R Nicoletti, I Denner, L
Citation: M. Marcelli et al., Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation, PROSTATE, 42(4), 2000, pp. 260-273

Authors: Ahlgren, G Pedersen, K Lundberg, S Aus, G Hugosson, J Abrahamsson, PA
Citation: G. Ahlgren et al., Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment, PROSTATE, 42(4), 2000, pp. 274-279

Authors: Willman, JH Holden, JA
Citation: Jh. Willman et Ja. Holden, Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate, PROSTATE, 42(4), 2000, pp. 280-286

Authors: Kim, CJ Kushima, R Okada, Y Seto, A
Citation: Cj. Kim et al., Establishment and characterization of a prostatic small-cell carcinoma cell line (PSK-I) derived from a patient with Klinefelter syndrome, PROSTATE, 42(4), 2000, pp. 287-294

Authors: Sun, BD Halmos, G Schally, AV Wang, XF Martinez, M
Citation: Bd. Sun et al., Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers, PROSTATE, 42(4), 2000, pp. 295-303

Authors: Bylund, A Zhang, JX Bergh, A Damber, JE Widmark, A Johansson, A Adlercreutz, H Aman, P Shepherd, MJ Hallmans, G
Citation: A. Bylund et al., Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice, PROSTATE, 42(4), 2000, pp. 304-314

Authors: Murphy, GP Elgamal, AAA Troychak, MJ Kenny, GM
Citation: Gp. Murphy et al., Follow-up ProstaScint (R) scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy, PROSTATE, 42(4), 2000, pp. 315-317

Authors: Murphy, GP Su, S Jarisch, J Kenny, GM
Citation: Gp. Murphy et al., Serum levels of PSMA, PROSTATE, 42(4), 2000, pp. 318-319

Authors: Kubota, T Hisatake, J Hisatake, Y Said, JW Chen, SS Holden, S Taguchi, H Koeffler, HP
Citation: T. Kubota et al., PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo, PROSTATE, 42(3), 2000, pp. 163-171

Authors: Rotem, R Tzivony, Y Flescher, E
Citation: R. Rotem et al., Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance, PROSTATE, 42(3), 2000, pp. 172-180

Authors: Filella, X Alcover, J Molina, R Corral, JM Carretero, P Ballesta, AM
Citation: X. Filella et al., Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia, PROSTATE, 42(3), 2000, pp. 181-185

Authors: Spiotto, MT Chung, TDK
Citation: Mt. Spiotto et Tdk. Chung, STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells, PROSTATE, 42(3), 2000, pp. 186-195

Authors: Costello, LC Liu, Y Zou, J Franklin, RB
Citation: Lc. Costello et al., Mitochondrial aconitase gene expression is regulated by testosterone and prolactin in prostate epithelial cells, PROSTATE, 42(3), 2000, pp. 196-202

Authors: Thomas, LN Wright, AS Lazier, CB Cohen, P Rittmaster, RS
Citation: Ln. Thomas et al., Prostatic involution in men taking finasteride is associated with elevatedlevels of insulin-like growth factor-binding proteins (IGFBPs)-2,-4, and-5, PROSTATE, 42(3), 2000, pp. 203-210

Authors: Jakob, CG Lewinski, K Kuciel, R Ostrowski, W Lebioda, L
Citation: Cg. Jakob et al., Crystal structure of human prostatic acid phosphatase, PROSTATE, 42(3), 2000, pp. 211-218
Risultati: << | 201-225 | 226-250 | 251-275 | 276-300 | >>